Inge Van de Walle

2.0k citations

33 papers · 1.2k indexed · h-index 16

Co-authors: Tom Taghon Jean Plum Georges Leclercq Magda De Smedt Greet De Smet Bart Vandekerckhove Pieter Van Vlierberghe Frank Speleman
Topics: Immune Cell Function and Interaction (7 papers)T-cell and B-cell Immunology (7 papers)Developmental Biology and Gene Regulation (7 papers)
Cited by: Immunology Hematology Cancer Research
Journals: Nature Nucleic Acids Research Nature Communications
Partner nations: Belgium United States France

In The Last Decade

Inge Van de Walle

27 papers receiving 1.2k citations

Peers

Countries citing papers authored by Inge Van de Walle

Since Specialization

Citations

This map shows the geographic impact of Inge Van de Walle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Van de Walle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Van de Walle more than expected).

Fields of papers citing papers by Inge Van de Walle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Van de Walle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Van de Walle. The network helps show where Inge Van de Walle may publish in the future.

Co-authorship network of co-authors of Inge Van de Walle

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Van de Walle. A scholar is included among the top collaborators of Inge Van de Walle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Van de Walle. Inge Van de Walle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization and efficacy of a C2-blocking antibody in a rat kidney transplant model 2025 ·Immunobiology ·(unknown),(unknown),(unknown),(unknown),(unknown),Yasmine Driege,(unknown),Erik Hack,(unknown),Daniëlle Krijgsman,Inge Van de Walle	0
2	Randomized phase I trial outcomes show safe and sustainable inhibition of classical and lectin complement pathways by empasiprubart 2025 ·Nature Communications ·Inge Van de Walle,(unknown),(unknown),(unknown),(unknown),P. Decker,(unknown),(unknown),Emma K. Persson,(unknown),Xing-Hong Leng,G.R. Andersen,Domenica Gandini,C. Erik Hack	0
3	Trial Design of the Phase 2 Study SHAMROCK Evaluating the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adult Kidney Transplant Recipients with Antibody-Mediated Rejection 2025 ·American Journal of Transplantation ·Georg A. Böhmig,Mark Haas,Philip F. Halloran,Stanley C. Jordan,Christophe Legendre,(unknown),(unknown),(unknown),Inge Van de Walle,Steven Nijs,Ashley Vo,Maarten Naesens	0
4	Complement activation by IgM autoantibodies linked to immune‐mediated neuropathies depends on C2 2024 ·European Journal of Neurology ·(unknown),(unknown),(unknown),(unknown),W. Ludo van der Pol,Nicolette C. Notermans,Monique C. Minnema,Jeanette H.W. Leusen,C. Erik Hack,Inge Van de Walle	0
5	Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model 2022 ·Brain Communications ·(unknown),Rhona McGonigal,Jennifer A. Barrie,(unknown),(unknown),(unknown),Denggao Yao,(unknown),Inge Van de Walle,Hugh J. Willison	13
6	Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda) 2022 ·Neurology ·Jeffrey C. Allen,Eduardo Nobile‐Orazio,Stojan Perić,Hans Katzberg,(unknown),Inge Van de Walle,(unknown),(unknown),(unknown),W. Ludo van der Pol	3
7	Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer 2020 ·Nature Communications ·(unknown),(unknown),(unknown),Stéphanie Liénart,Orian Bricard,(unknown),(unknown),(unknown),Gitte De Boeck,(unknown),Inge Van de Walle,Bas van der Woning,Michael Saunders,Hans de Haard,(unknown),Wim Maes,Hans Deckmyn,Pierre G. Coulie,Nicolas van Baren,Sophie Lucas	104
8	PHF6 Expression Levels Impact Human Hematopoietic Stem Cell Differentiation 2020 ·Frontiers in Cell and Developmental Biology ·Siebe Loontiens,(unknown),(unknown),Inge Van de Walle,Finola E. Moore,(unknown),Suzanne Vanhauwaert,Filip Matthijssens,David M. Langenau,Frank Speleman,Pieter Van Vlierberghe,Kaat Durinck,Tom Taghon	5
9	A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of anERG-driven transcriptional network 2016 ·Nucleic Acids Research ·Ashwin Unnikrishnan,Yi Fang Guan,Yizhou Huang,Dominik Beck,Julie A.I. Thoms,Sofie Peirs,Kathy Knezevic,Shiyong Ma,Inge Van de Walle,(unknown),(unknown),Ling Zhong,Mark J. Raftery,Tom Taghon,Jonas Larsson,Karen L. MacKenzie,Pieter Van Vlierberghe,Jason W.H. Wong,John E. Pimanda	16
10	Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia 2015 ·Leukemia ·Kaat Durinck,Wouter Van Loocke,Joni Van der Meulen,Inge Van de Walle,Maté Ongenaert,Pieter Rondou,Annelynn Wallaert,Charles E. de Bock,Nadine Van Roy,Bruce Poppe,Jan Cools,Jean Soulier,Tom Taghon,Frank Speleman,Pieter Van Vlierberghe	19
11	Characterization and Isolation of Human T Cell Progenitors 2015 ·Methods in molecular biology ·Inge Van de Walle,(unknown),Tom Taghon	3
12	The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 2014 ·Haematologica ·Kaat Durinck,Annelynn Wallaert,Inge Van de Walle,Wouter Van Loocke,Pieter‐Jan Volders,Suzanne Vanhauwaert,Ellen Geerdens,Yves Benoît,Nilmadhab Roy,Bruce Poppe,Jean Soulier,Jan Cools,Pieter Mestdagh,Jo Vandesompele,Pieter Rondou,Pieter Van Vlierberghe,Tom Taghon,Frank Speleman	40
13	MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia 2014 ·Leukemia ·Evelien Mets,Joni Van der Meulen,Gert Van Peer,Michael Boice,Pieter Mestdagh,Inge Van de Walle,Tim Lammens,Steven Goossens,Barbara De Moerloose,Yves Benoît,Nadine Van Roy,Emmanuelle Clappier,Bruce Poppe,Jo Vandesompele,(unknown),Tom Taghon,Pieter Rondou,Jean Soulier,Pieter Van Vlierberghe,Frank Speleman	88
14	Primate lentiviral Nef proteins deregulate T-cell development by multiple mechanisms 2013 ·Retrovirology ·Anouk Van Nuffel,Kevin K. Ariën,Veronique Stove,Michael Schindler,Eduardo O’Neill,(unknown),Inge Van de Walle,Evelien Naessens,Hanne Vanderstraeten,(unknown),Tom Taghon,Kati Pulkkinen,Kalle Saksela,J. Víctor García,O. Fackler,Frank Kirchhoff,Bruno Verhasselt	3
15	Notch Signaling During Human T cell Development 2012 ·Current topics in microbiology and immunology ·Tom Taghon,(unknown),Inge Van de Walle	39
16	Intrinsic Dynamics of the Fat Graft 2012 ·Plastic & Reconstructive Surgery ·(unknown),Heidi Declercq,Filip Stillaert,(unknown),Inge Van de Walle,Maria Cornelissen,Phillip Blondeel	8
17	Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions 2011 ·Blood ·Inge Van de Walle,Greet De Smet,(unknown),Magda De Smedt,(unknown),Bart Vandekerckhove,Georges Leclercq,Jean Plum,Jon C. Aster,Irwin D. Bernstein,Cynthia J. Guidos,Bruno Kyewski,Tom Taghon	67
18	A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia 2011 ·Nature ·Apostolos Klinakis,Camille Lobry,Omar Abdel‐Wahab,Philmo Oh,Hiroshi Haeno,Silvia Buonamici,Inge Van de Walle,Séverine Cathelin,Thomas Trimarchi,Elisa Araldi,Cynthia Liu,Sherif Ibrahim,(unknown),Jiří Zavadil,Argiris Efstratiadis,Tom Taghon,Franziska Michor,Ross L. Levine,Iannis Aifantis	271
19	Temporal variation and high-resolution spatial heterogeneity in soil CO2 efflux in a short-rotation tree plantation 2007 ·Tree Physiology ·Inge Van de Walle,Roeland Samson,(unknown),Kris Verheyen,Raoul Lemeur	7
20	Human Immunodeficiency Virus Nef Induces Rapid Internalization of the T-Cell Coreceptor CD8αβ 2005 ·Journal of Virology ·Veronique Stove,Inge Van de Walle,Evelien Naessens,Elisabeth Coene,Christophe P. Stove,Jean Plum,Bruno Verhasselt	64

About Inge Van de Walle

Inge Van de Walle is a scholar working on Transplantation, Immunology and Virology, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (7 papers) and Developmental Biology and Gene Regulation (7 papers). The work is most often cited by research in Immunology (383 citations), Hematology (187 citations) and Cancer Research (206 citations). Inge Van de Walle has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Tom Taghon, Jean Plum, Georges Leclercq, Magda De Smedt, Greet De Smet, Bart Vandekerckhove, Pieter Van Vlierberghe, Frank Speleman, Bruce Poppe and Jiří Zavadil. Their work appears in journals such as Nature, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact